KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Revenue (2016 - 2026)

Globus Medical filings provide 15 years of Revenue readings, the most recent being $826.4 million for Q4 2025.

  • On a quarterly basis, Revenue rose 25.73% to $826.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 billion, a 16.65% increase, with the full-year FY2025 number at $2.9 billion, up 16.65% from a year prior.
  • Revenue hit $826.4 million in Q4 2025 for Globus Medical, up from $769.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $826.4 million in Q4 2025 to a low of $227.3 million in Q1 2021.
  • Median Revenue over the past 5 years was $337.6 million (2023), compared with a mean of $450.4 million.
  • Biggest five-year swings in Revenue: surged 124.6% in 2023 and later dropped 1.41% in 2025.
  • Globus Medical's Revenue stood at $250.0 million in 2021, then grew by 9.79% to $274.5 million in 2022, then skyrocketed by 124.6% to $616.5 million in 2023, then rose by 6.61% to $657.3 million in 2024, then rose by 25.73% to $826.4 million in 2025.
  • The last three reported values for Revenue were $826.4 million (Q4 2025), $769.0 million (Q3 2025), and $745.3 million (Q2 2025) per Business Quant data.